Sanjay Subramanian - Net Worth and Insider Trading

Sanjay Subramanian Net Worth

The estimated net worth of Sanjay Subramanian is at least $187,503 dollars as of 2024-06-04. Sanjay Subramanian is the SVP, CFO of Inozyme Pharma Inc and owns about 27,100 shares of Inozyme Pharma Inc (INZY) stock worth over $126,286. Sanjay Subramanian is also the CFO of Ocugen Inc and owns about 35,591 shares of Ocugen Inc (OCGN) stock worth over $61,217. Details can be seen in Sanjay Subramanian's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sanjay Subramanian has not made any transactions after 2022-04-19 and currently still holds the listed stock(s).

Transaction Summary of Sanjay Subramanian

To

Sanjay Subramanian Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sanjay Subramanian owns 2 companies in total, including Ocugen Inc (OCGN) , and Inozyme Pharma Inc (INZY) .

Click here to see the complete history of Sanjay Subramanian’s form 4 insider trades.

Insider Ownership Summary of Sanjay Subramanian

Ticker Comapny Transaction Date Type of Owner
OCGN Ocugen Inc 2022-01-03 Chief Financial Officer
INZY Inozyme Pharma Inc 2022-04-19 SVP & CFO

Sanjay Subramanian Latest Holdings Summary

Sanjay Subramanian currently owns a total of 2 stocks. Among these stocks, Sanjay Subramanian owns 27,100 shares of Inozyme Pharma Inc (INZY) as of April 19, 2022, with a value of $126,286 and a weighting of 67.35%. Sanjay Subramanian also owns 35,591 shares of Ocugen Inc (OCGN) as of October 26, 2021, with a value of $61,217 and a weighting of 32.65%.

Latest Holdings of Sanjay Subramanian

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INZY Inozyme Pharma Inc 2022-04-19 27,100 4.66 126,286
OCGN Ocugen Inc 2021-10-26 35,591 1.72 61,217

Holding Weightings of Sanjay Subramanian


Sanjay Subramanian Form 4 Trading Tracker

According to the SEC Form 4 filings, Sanjay Subramanian has made a total of 1 transactions in Inozyme Pharma Inc (INZY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Inozyme Pharma Inc is the acquisition of 27,100 shares on April 19, 2022, which cost Sanjay Subramanian around $99,999.

According to the SEC Form 4 filings, Sanjay Subramanian has made a total of 9 transactions in Ocugen Inc (OCGN) over the past 5 years, including 2 buys and 7 sells. The most-recent trade in Ocugen Inc is the sale of 10,000 shares on October 26, 2021, which brought Sanjay Subramanian around $110,700.

Insider Trading History of Sanjay Subramanian

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sanjay Subramanian Trading Performance

GuruFocus tracks the stock performance after each of Sanjay Subramanian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sanjay Subramanian is 11.01%. GuruFocus also compares Sanjay Subramanian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sanjay Subramanian within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sanjay Subramanian's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sanjay Subramanian

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.51 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.45 LIMIT LIMIT LIMIT LIMIT LIMIT

Sanjay Subramanian Ownership Network

Ownership Network List of Sanjay Subramanian

No Data

Ownership Network Relation of Sanjay Subramanian

Insider Network Chart

Sanjay Subramanian Owned Company Details

What does Ocugen Inc do?

Who are the key executives at Ocugen Inc?

Sanjay Subramanian is the Chief Financial Officer of Ocugen Inc. Other key executives at Ocugen Inc include CFO/CBO Quan Anh Vu , director & Chief Executive Officer Shankar Musunuri , and Chief Scientific Officer Arun Upadhyay .

Ocugen Inc (OCGN) Insider Trades Summary

Over the past 18 months, Sanjay Subramanian made no insider transaction in Ocugen Inc (OCGN). Other recent insider transactions involving Ocugen Inc (OCGN) include a net sale of 295,809 shares made by Shankar Musunuri , and a net purchase of 200,278 shares made by Junge Zhang .

In summary, during the past 3 months, insiders sold 0 shares of Ocugen Inc (OCGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 295,809 shares of Ocugen Inc (OCGN) were sold and 200,278 shares were bought by its insiders, resulting in a net sale of 95,531 shares.

Ocugen Inc (OCGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ocugen Inc Insider Transactions

No Available Data

Sanjay Subramanian Mailing Address

Above is the net worth, insider trading, and ownership report for Sanjay Subramanian. You might contact Sanjay Subramanian via mailing address: 5 Great Valley Parkway, Suite 160, Malvern Pa 19355.

Discussions on Sanjay Subramanian

No discussions yet.